<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List
href="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/filelist.xml">
<link rel=Edit-Time-Data
href="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Zachary Landman</o:Author>
  <o:LastAuthor>Rosenberg, Daniel M</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>3</o:TotalTime>
  <o:Created>2021-07-30T17:23:00Z</o:Created>
  <o:LastSaved>2021-07-30T17:23:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>2839</o:Words>
  <o:Characters>16184</o:Characters>
  <o:Company>UCSF-DEB</o:Company>
  <o:Lines>134</o:Lines>
  <o:Paragraphs>37</o:Paragraphs>
  <o:CharactersWithSpaces>18986</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData
href="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/themedata.thmx">
<link rel=colorSchemeMapping
href="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>JA</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2010TableStyleRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:EN.InstantFormat>&lt;ENInstantFormat&gt;&lt;Enabled&gt;0&lt;/Enabled&gt;&lt;ScanUnformatted&gt;1&lt;/ScanUnformatted&gt;&lt;ScanChanges&gt;1&lt;/ScanChanges&gt;&lt;Suspended&gt;0&lt;/Suspended&gt;&lt;/ENInstantFormat&gt;</w:EN.InstantFormat>
   <w:EN.Layout>&lt;ENLayout&gt;&lt;Style&gt;Numbered&lt;/Style&gt;&lt;LeftDelim&gt;{&lt;/LeftDelim&gt;&lt;RightDelim&gt;}&lt;/RightDelim&gt;&lt;FontName&gt;Calibri&lt;/FontName&gt;&lt;FontSize&gt;12&lt;/FontSize&gt;&lt;ReflistTitle&gt;REFERENCES&lt;/ReflistTitle&gt;&lt;StartingRefnum&gt;1&lt;/StartingRefnum&gt;&lt;FirstLineIndent&gt;0&lt;/FirstLineIndent&gt;&lt;HangingIndent&gt;720&lt;/HangingIndent&gt;&lt;LineSpacing&gt;0&lt;/LineSpacing&gt;&lt;SpaceAfter&gt;0&lt;/SpaceAfter&gt;&lt;HyperlinksEnabled&gt;0&lt;/HyperlinksEnabled&gt;&lt;HyperlinksVisible&gt;0&lt;/HyperlinksVisible&gt;&lt;EnableBibliographyCategories&gt;0&lt;/EnableBibliographyCategories&gt;&lt;/ENLayout&gt;</w:EN.Layout>
   <w:EN.Libraries>&lt;Libraries&gt;&lt;item
    db-id=&quot;zvsswrav8t2apbep2dbpv25ufvpprfe9rpex&quot;&gt;MasterLibrary-2017-0828&lt;record-ids&gt;&lt;item&gt;10&lt;/item&gt;&lt;item&gt;40&lt;/item&gt;&lt;item&gt;154&lt;/item&gt;&lt;item&gt;235&lt;/item&gt;&lt;item&gt;709&lt;/item&gt;&lt;item&gt;2522&lt;/item&gt;&lt;item&gt;2524&lt;/item&gt;&lt;item&gt;2559&lt;/item&gt;&lt;item&gt;3319&lt;/item&gt;&lt;item&gt;3330&lt;/item&gt;&lt;item&gt;3927&lt;/item&gt;&lt;item&gt;4061&lt;/item&gt;&lt;item&gt;4062&lt;/item&gt;&lt;item&gt;4063&lt;/item&gt;&lt;/record-ids&gt;&lt;/item&gt;&lt;/Libraries&gt;</w:EN.Libraries>
  </w:DocumentVariables>
  <w:DoNotOptimizeForBrowser/>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="376">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="59" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Hyperlink"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342208091 0 0 415 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"\FF2D\FF33 \660E\671D";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:"Lucida Grande";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520090897 1342218751 0 0 447 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 5 4 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536858881 -1073711013 9 0 511 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Comment Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Header Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:center 3.25in right 6.5in;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Footer Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:center 3.25in right 6.5in;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:#0563C1;
	mso-themecolor:hyperlink;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"Comment Text";
	mso-style-link:"Comment Subject Char";
	mso-style-next:"Comment Text";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Lucida Grande",sans-serif;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Footer;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Lucida Grande",sans-serif;
	mso-ascii-font-family:"Lucida Grande";
	mso-hansi-font-family:"Lucida Grande";
	mso-bidi-font-family:"Lucida Grande";}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Comment Text";}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Comment Text Char";
	mso-style-link:"Comment Subject";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-weight:bold;}
p.EndNoteBibliographyTitle, li.EndNoteBibliographyTitle, div.EndNoteBibliographyTitle
	{mso-style-name:"EndNote Bibliography Title";
	mso-style-unhide:no;
	margin:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.EndNoteBibliography, li.EndNoteBibliography, div.EndNoteBibliography
	{mso-style-name:"EndNote Bibliography";
	mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:12.0pt;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") fs;
	mso-footnote-continuation-separator:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") fcs;
	mso-endnote-separator:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") es;
	mso-endnote-continuation-separator:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") ecs;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:.9in .9in .9in .9in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-even-header:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") eh1;
	mso-header:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") h1;
	mso-even-footer:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") ef1;
	mso-footer:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") f1;
	mso-first-header:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") fh1;
	mso-first-footer:url("NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:1;
	mso-list-type:hybrid;
	mso-list-template-ids:1 1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l0:level1
	{mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l0:level2
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l0:level3
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l0:level4
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l0:level5
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l0:level6
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l0:level7
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l0:level8
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l0:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l1
	{mso-list-id:384139103;
	mso-list-type:hybrid;
	mso-list-template-ids:-1640567088 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2
	{mso-list-id:679744336;
	mso-list-type:hybrid;
	mso-list-template-ids:-1054682622 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3
	{mso-list-id:975258321;
	mso-list-type:hybrid;
	mso-list-template-ids:165984508 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4
	{mso-list-id:1614676746;
	mso-list-type:hybrid;
	mso-list-template-ids:-1564310420 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5
	{mso-list-id:1657150230;
	mso-list-type:hybrid;
	mso-list-template-ids:2108088874 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l6
	{mso-list-id:1785155646;
	mso-list-type:hybrid;
	mso-list-template-ids:1611403182 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l6:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l6:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l6:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l6:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l6:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l7
	{mso-list-id:1862207511;
	mso-list-type:hybrid;
	mso-list-template-ids:-709702754 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l7:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l7:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l7:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l7:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l7:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l7:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l7:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l7:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l7:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l8
	{mso-list-id:1974601384;
	mso-list-type:hybrid;
	mso-list-template-ids:769525202 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9
	{mso-list-id:1992513413;
	mso-list-type:hybrid;
	mso-list-template-ids:-944981506 67698689 67698691 67698693 -436726108 67698691 67698693 67698689 67698691 67698693;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
table.MsoTableGrid
	{mso-style-name:"Table Grid";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2049"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US link="#0563C1" vlink="#954F72" style='tab-interval:.5in;
word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:
normal'><span style='font-size:16.0pt;mso-bidi-font-family:Arial'>Consensus
Guidelines for Screening &amp; Management of Hyperbilirubinemia in Neonates <o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;mso-pagination:none;
mso-layout-grid-align:none;text-autospace:none'><b style='mso-bidi-font-weight:
normal'><span style='font-size:14.0pt;mso-bidi-font-family:Arial'>UCSF (NC)<sup><span
style='mso-bidi-font-weight:bold'>2</span></sup> (Northern CA Neonatology
Consortium)<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='mso-bidi-font-family:Arial'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='font-size:16.0pt'>Executive summary<o:p></o:p></span></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Objectives<o:p></o:p></b></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l3 level1 lfo3'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Standardize the approach to screening and
management of hyperbilirubinemia in neonates <span style='font-family:"Cambria",serif'>&#8805;</span>
35 weeks gestational age (GA) across the consortium hospitals using current
practice standards and best available evidence<b style='mso-bidi-font-weight:
normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l3 level1 lfo3'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Improve quality and safety of care for neonates <span
style='font-family:"Cambria",serif'>&#8805; 35 weeks GA</span> with
hyperbilirubinemia; specifically:<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l3 level2 lfo3'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Improve recognition and efficient management of
infants at high risk for complications of hyperbilirubinemia<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l3 level2 lfo3'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Decrease unnecessary testing<b style='mso-bidi-font-weight:
normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l3 level2 lfo3'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Deliver safe, effective, and appropriate
phototherapy<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpLast style='margin-left:.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l3 level2 lfo3'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Decrease unnecessary hospital days<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Recommendations<o:p></o:p></b></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l6 level1 lfo9'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Promote &amp; support successful breastfeeding<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l6 level1 lfo9'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Perform a systematic assessment before newborn
discharge for risk of severe hyperbilirubinemia<b style='mso-bidi-font-weight:
normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l6 level1 lfo9'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Treat newborns with phototherapy or exchange
transfusion when indicated to prevent the development of severe
hyperbilirubinemia and kernicterus<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l6 level2 lfo9'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Revisions to 2004 AAP Guidelines: Provide
customized thresholds based on gestational age, neurotoxicity risk factors, and
hours of life for each infant</p>

<p class=MsoListParagraphCxSpLast style='margin-left:.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l6 level2 lfo9'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Increase the threshold for phototherapy and
exchange transfusion for most infants based on recent evidence given the
extremely low rates of kernicterus and the possible risk of phototherapy
causing adverse outcomes</p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Methods<o:p></o:p></b></p>

<p class=MsoNormal>This guideline was developed through local consensus based
on published evidence and expert opinion as part of the UCSF Northern
California Neonatal Consortium.</p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Metrics Plan<o:p></o:p></b></p>

<p class=MsoNormal>Monitoring of frequency of phototherapy use during the birth
admission and readmissions for phototherapy.</p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:
normal'><span style='font-size:16.0pt;mso-bidi-font-family:Arial'>Consensus
Guidelines for Screening &amp; Management of Hyperbilirubinemia in Neonates</span><o:p></o:p></b></p>

<p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:
normal'><span style='font-size:14.0pt;mso-bidi-font-family:Arial'>UCSF (NC)<sup><span
style='mso-bidi-font-weight:bold'>2</span></sup> (Northern CA Neonatology
Consortium)</span><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>PART I: Introduction<o:p></o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l9 level1 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Jaundice / hyperbilirubinemia is common in
newborns<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level2 lfo4'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Most jaundice is benign, but bilirubin can be
toxic at very high levels<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level2 lfo4'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Severe hyperbilirubinemia can lead to acute
bilirubin encephalopathy or kernicterus in rare cases<b style='mso-bidi-font-weight:
normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level2 lfo4'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Goal of developing standardized clinical
practices is to reduce incidence of severe hyperbilirubinemia and kernicterus
while minimizing risks of unintended harm (family anxiety, decreased
breastfeeding, unnecessary costs or treatment, potential risk of phototherapy)<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level1 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>AAP 2004 Clinical Practice Guideline (for newborns
<span style='font-family:"Cambria",serif'>&#8805;</span>35 weeks gestational
age)[1]<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level2 lfo4'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Outline of 2004 recommendations:<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level3 lfo4'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Promote &amp; support successful breastfeeding<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level3 lfo4'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Perform a systematic assessment before newborn
discharge for risk of severe hyperbilirubinemia<b style='mso-bidi-font-weight:
normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level3 lfo4'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Provide early &amp; focused follow-up based on
risk assessment<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level3 lfo4'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Treat newborns with phototherapy or exchange
transfusion when indicated to prevent the development of severe
hyperbilirubinemia and kernicterus<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level4 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Product = nomogram guidelines for phototherapy
&amp; exchange transfusion thresholds <b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level2 lfo4'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Concerns:<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level3 lfo4'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>2004 guidelines for phototherapy &amp; exchange
transfusion are based on limited evidence, insufficient to make specific
recommendations </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level4 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>No population-based studies of kernicterus
incidence</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level4 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>No studies to allow estimation of number needed
to treat (NNT)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level3 lfo4'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>2004 guideline recommends abrupt change in
treatment thresholds at 38 weeks gestation</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level3 lfo4'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Research since 2004 suggests guideline leads to
overtreatment with phototherapy and should be changed<b style='mso-bidi-font-weight:
normal'><o:p></o:p></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level4 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rarity of kernicterus<!--[if supportFields]><span
style='mso-element:field-begin'></span> ADDIN EN.CITE
&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Brooks&lt;/Author&gt;&lt;Year&gt;2011&lt;/Year&gt;&lt;RecNum&gt;10&lt;/RecNum&gt;&lt;DisplayText&gt;[2]&lt;/DisplayText&gt;&lt;record&gt;&lt;rec-number&gt;10&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;key
app=&quot;EN&quot; db-id=&quot;zvsswrav8t2apbep2dbpv25ufvpprfe9rpex&quot;
timestamp=&quot;0&quot;&gt;10&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-type
name=&quot;Journal
Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Brooks,
J. C.&lt;/author&gt;&lt;author&gt;Fisher-Owens, S.
A.&lt;/author&gt;&lt;author&gt;Wu, Y. W.&lt;/author&gt;&lt;author&gt;Strauss,
D. J.&lt;/author&gt;&lt;author&gt;Newman, T.
B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Life
Expectancy Project, San Francisco, California, USA. brooks@lifeexpectancy.org&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Evidence
suggests there was not a &amp;quot;resurgence&amp;quot; of kernicterus in the
1990s&lt;/title&gt;&lt;secondary-title&gt;Pediatrics&lt;/secondary-title&gt;&lt;/titles&gt;&lt;periodical&gt;&lt;full-title&gt;Pediatrics&lt;/full-title&gt;&lt;/periodical&gt;&lt;pages&gt;672-9&lt;/pages&gt;&lt;volume&gt;127&lt;/volume&gt;&lt;number&gt;4&lt;/number&gt;&lt;edition&gt;2011/03/30&lt;/edition&gt;&lt;dates&gt;&lt;year&gt;2011&lt;/year&gt;&lt;pub-dates&gt;&lt;date&gt;Apr&lt;/date&gt;&lt;/pub-dates&gt;&lt;/dates&gt;&lt;isbn&gt;1098-4275
(Electronic)&amp;#xD;0031-4005
(Linking)&lt;/isbn&gt;&lt;accession-num&gt;21444599&lt;/accession-num&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=21444599&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;electronic-resource-num&gt;peds.2010-2476
[pii]&amp;#xD;10.1542/peds.2010-2476&lt;/electronic-resource-num&gt;&lt;language&gt;eng&lt;/language&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<span
style='mso-element:field-separator'></span><![endif]--><span style='mso-no-proof:
yes'>[2]</span><!--[if supportFields]><span style='mso-element:field-end'></span><![endif]-->,
especially in term babies without hemolysis<!--[if supportFields]><sup><span
style='mso-element:field-begin'></span> ADDIN EN.CITE <span style='mso-element:
field-begin'></span><span style='mso-spacerun:yes'></span>ADDIN EN.CITE.DATA <![if gte mso 9]><xml>
 <w:data>3C456E644E6F74653E3C436974653E3C417574686F723E47616D616C656C64696E3C2F417574686F723E3C596561723E323031313C2F596561723E3C5265634E756D3E333331393C2F5265634E756D3E3C446973706C6179546578743E5B332D375D3C2F446973706C6179546578743E3C7265636F72643E3C7265632D6E756D6265723E333331393C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2230223E333331393C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E47616D616C656C64696E2C20522E3C2F617574686F723E3C617574686F723E49736B616E6465722C20492E3C2F617574686F723E3C617574686F723E53656F75642C20492E3C2F617574686F723E3C617574686F723E41626F726179612C20482E3C2F617574686F723E3C617574686F723E417261766B696E2C20412E3C2F617574686F723E3C617574686F723E53616D70736F6E2C20502E20442E3C2F617574686F723E3C617574686F723E57656E6E626572672C20522E20502E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C617574682D616464726573733E4465706172746D656E74206F6620506564696174726963732C20436169726F20556E69766572736974792C20436169726F2C2045677970742E3C2F617574682D616464726573733E3C7469746C65733E3C7469746C653E5269736B20666163746F727320666F72206E6575726F746F78696369747920696E206E6577626F726E73207769746820736576657265206E656F6E6174616C20687970657262696C69727562696E656D69613C2F7469746C653E3C7365636F6E646172792D7469746C653E506564696174726963733C2F7365636F6E646172792D7469746C653E3C616C742D7469746C653E506564696174726963733C2F616C742D7469746C653E3C2F7469746C65733E3C706572696F646963616C3E3C66756C6C2D7469746C653E506564696174726963733C2F66756C6C2D7469746C653E3C2F706572696F646963616C3E3C616C742D706572696F646963616C3E3C66756C6C2D7469746C653E506564696174726963733C2F66756C6C2D7469746C653E3C2F616C742D706572696F646963616C3E3C70616765733E653932352D33313C2F70616765733E3C766F6C756D653E3132383C2F766F6C756D653E3C6E756D6265723E343C2F6E756D6265723E3C6B6579776F7264733E3C6B6579776F72643E41424F20426C6F6F642D47726F75702053797374656D3C2F6B6579776F72643E3C6B6579776F72643E42696C69727562696E2F2A626C6F6F643C2F6B6579776F72643E3C6B6579776F72643E42696F6C6F676963616C204D61726B6572732F626C6F6F643C2F6B6579776F72643E3C6B6579776F72643E426C6F6F642047726F757020496E636F6D7061746962696C6974792F626C6F6F642F636F6D706C69636174696F6E733C2F6B6579776F72643E3C6B6579776F72643E426F6479205765696768743C2F6B6579776F72643E3C6B6579776F72643E436F686F727420537475646965733C2F6B6579776F72643E3C6B6579776F72643E4572797468726F626C6173746F7369732C20466574616C2F626C6F6F643C2F6B6579776F72643E3C6B6579776F72643E46656D616C653C2F6B6579776F72643E3C6B6579776F72643E48756D616E733C2F6B6579776F72643E3C6B6579776F72643E487970657262696C69727562696E656D69612C204E656F6E6174616C2F626C6F6F642F2A636F6D706C69636174696F6E733C2F6B6579776F72643E3C6B6579776F72643E496E66616E742C204E6577626F726E3C2F6B6579776F72643E3C6B6579776F72643E496E66616E742C205072656D61747572653C2F6B6579776F72643E3C6B6579776F72643E2A496E66616E742C205072656D61747572652C2044697365617365732F626C6F6F642F6574696F6C6F67793C2F6B6579776F72643E3C6B6579776F72643E4B65726E696374657275732F626C6F6F642F65706964656D696F6C6F67792F2A6574696F6C6F67793C2F6B6579776F72643E3C6B6579776F72643E4C6F676973746963204D6F64656C733C2F6B6579776F72643E3C6B6579776F72643E4D616C653C2F6B6579776F72643E3C6B6579776F72643E524F432043757276653C2F6B6579776F72643E3C6B6579776F72643E52682D487220426C6F6F642D47726F75702053797374656D3C2F6B6579776F72643E3C6B6579776F72643E5269736B20466163746F72733C2F6B6579776F72643E3C6B6579776F72643E5365707369732F636F6D706C69636174696F6E733C2F6B6579776F72643E3C2F6B6579776F7264733E3C64617465733E3C796561723E323031313C2F796561723E3C7075622D64617465733E3C646174653E4F63743C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C6973626E3E313039382D343237352028456C656374726F6E696329262378443B303033312D3430303520284C696E6B696E67293C2F6973626E3E3C616363657373696F6E2D6E756D3E32313931313335323C2F616363657373696F6E2D6E756D3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E687474703A2F2F7777772E6E6362692E6E6C6D2E6E69682E676F762F7075626D65642F32313931313335323C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C637573746F6D323E333138323834373C2F637573746F6D323E3C656C656374726F6E69632D7265736F757263652D6E756D3E31302E313534322F706564732E323031312D303230363C2F656C656374726F6E69632D7265736F757263652D6E756D3E3C2F7265636F72643E3C2F436974653E3C436974653E3C417574686F723E4B757A6E69657769637A3C2F417574686F723E3C596561723E323031343C2F596561723E3C5265634E756D3E323532323C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E323532323C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2230223E323532323C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E4B757A6E69657769637A2C204D69636861656C20573C2F617574686F723E3C617574686F723E5769636B72656D6173696E6768652C20416E6472656120433C2F617574686F723E3C617574686F723E57752C2059766F6E6E6520573C2F617574686F723E3C617574686F723E4D6343756C6C6F63682C20436861726C657320453C2F617574686F723E3C617574686F723E57616C73682C2045696C65656E204D3C2F617574686F723E3C617574686F723E57692C20536F6F72613C2F617574686F723E3C617574686F723E4E65776D616E2C2054686F6D617320423C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C7469746C65733E3C7469746C653E496E636964656E63652C204574696F6C6F67792C20616E64204F7574636F6D6573206F662048617A6172646F757320487970657262696C69727562696E656D696120696E204E6577626F726E732E3C2F7469746C653E3C7365636F6E646172792D7469746C653E506564696174726963733C2F7365636F6E646172792D7469746C653E3C2F7469746C65733E3C706572696F646963616C3E3C66756C6C2D7469746C653E506564696174726963733C2F66756C6C2D7469746C653E3C2F706572696F646963616C3E3C70616765733E706564732E323031342D303938373C2F70616765733E3C64617465733E3C796561723E323031343C2F796561723E3C2F64617465733E3C7075626C69736865723E416D65726963616E2041636164656D79206F6620506564696174726963733C2F7075626C69736865723E3C616363657373696F6E2D6E756D3E32353039323934333C2F616363657373696F6E2D6E756D3E3C6C6162656C3E7230383136353C2F6C6162656C3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E687474703A2F2F706564696174726963732E6161707075626C69636174696F6E732E6F72672F636F6E74656E742F3133342F332F3530343C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C656C656374726F6E69632D7265736F757263652D6E756D3E31302E313534322F706564732E323031342D303938373C2F656C656374726F6E69632D7265736F757263652D6E756D3E3C6C616E67756167653E456E676C6973683C2F6C616E67756167653E3C2F7265636F72643E3C2F436974653E3C436974653E3C417574686F723E57753C2F417574686F723E3C596561723E323031353C2F596561723E3C5265634E756D3E333333303C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E333333303C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2230223E333333303C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E57752C20592E20572E3C2F617574686F723E3C617574686F723E4B757A6E69657769637A2C204D2E20572E3C2F617574686F723E3C617574686F723E5769636B72656D6173696E6768652C20412E20432E3C2F617574686F723E3C617574686F723E57616C73682C20452E204D2E3C2F617574686F723E3C617574686F723E57692C20532E3C2F617574686F723E3C617574686F723E4D6343756C6C6F63682C20432E20452E3C2F617574686F723E3C617574686F723E4E65776D616E2C20542E20422E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C617574682D616464726573733E4465706172746D656E74206F66204E6575726F6C6F67792C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F324465706172746D656E74206F6620506564696174726963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F2E262378443B4465706172746D656E74206F6620506564696174726963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F334469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E642E262378443B4465706172746D656E74206F662045706964656D696F6C6F677920616E642042696F737461746973746963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F2E262378443B4469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E642E262378443B4465706172746D656E74206F6620506564696174726963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F334469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E64344465706172746D656E74206F662045706964656D696F6C6F677920616E642042696F737461746973746963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F2E3C2F617574682D616464726573733E3C7469746C65733E3C7469746C653E5269736B20666F7220636572656272616C2070616C737920696E20696E66616E7473207769746820746F74616C20736572756D2062696C69727562696E206C6576656C73206174206F722061626F7665207468652065786368616E6765207472616E73667573696F6E207468726573686F6C643A206120706F70756C6174696F6E2D62617365642073747564793C2F7469746C653E3C7365636F6E646172792D7469746C653E4A414D4120506564696174723C2F7365636F6E646172792D7469746C653E3C616C742D7469746C653E4A414D4120706564696174726963733C2F616C742D7469746C653E3C2F7469746C65733E3C70616765733E3233392D34363C2F70616765733E3C766F6C756D653E3136393C2F766F6C756D653E3C6E756D6265723E333C2F6E756D6265723E3C64617465733E3C796561723E323031353C2F796561723E3C7075622D64617465733E3C646174653E4D617220313C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C6973626E3E323136382D363231312028456C656374726F6E696329262378443B323136382D3632303320284C696E6B696E67293C2F6973626E3E3C616363657373696F6E2D6E756D3E32353536303932303C2F616363657373696F6E2D6E756D3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E687474703A2F2F7777772E6E6362692E6E6C6D2E6E69682E676F762F7075626D65642F32353536303932303C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C656C656374726F6E69632D7265736F757263652D6E756D3E31302E313030312F6A616D61706564696174726963732E323031342E333033363C2F656C656374726F6E69632D7265736F757263652D6E756D3E3C2F7265636F72643E3C2F436974653E3C436974653E3C417574686F723E4562626573656E3C2F417574686F723E3C596561723E323031323C2F596561723E3C5265634E756D3E323535393C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E323535393C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2230223E323535393C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E4562626573656E2C20462E3C2F617574686F723E3C617574686F723E426A657272652C204A2E20562E3C2F617574686F723E3C617574686F723E56616E64626F72672C20502E204B2E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C617574682D616464726573733E4465706172746D656E74206F662050616564696174726963732C2041616C626F726720486F73706974616C2C2041617268757320556E697665727369747920486F73706974616C2C2041616C626F72672C2044656E6D61726B2E20666540726E2E646B3C2F617574682D616464726573733E3C7469746C65733E3C7469746C653E52656C6174696F6E206265747765656E20736572756D2062696C69727562696E206C6576656C73202667743B2F3D343530206D756D6F6C2F4C20616E642062696C69727562696E20656E63657068616C6F70617468793B20612044616E69736820706F70756C6174696F6E2D62617365642073747564793C2F7469746C653E3C7365636F6E646172792D7469746C653E416374612050616564696174723C2F7365636F6E646172792D7469746C653E3C616C742D7469746C653E416374612070616564696174726963613C2F616C742D7469746C653E3C2F7469746C65733E3C70616765733E3338342D393C2F70616765733E3C766F6C756D653E3130313C2F766F6C756D653E3C6E756D6265723E343C2F6E756D6265723E3C6B6579776F7264733E3C6B6579776F72643E42696C69727562696E2F2A626C6F6F643C2F6B6579776F72643E3C6B6579776F72643E44656E6D61726B2F65706964656D696F6C6F67793C2F6B6579776F72643E3C6B6579776F72643E46656D616C653C2F6B6579776F72643E3C6B6579776F72643E466F6C6C6F772D557020537475646965733C2F6B6579776F72643E3C6B6579776F72643E48756D616E733C2F6B6579776F72643E3C6B6579776F72643E496E636964656E63653C2F6B6579776F72643E3C6B6579776F72643E496E66616E742C204E6577626F726E3C2F6B6579776F72643E3C6B6579776F72643E496E66616E742C205072656D61747572653C2F6B6579776F72643E3C6B6579776F72643E496E66616E742C205072656D61747572652C2044697365617365732F2A65706964656D696F6C6F67793C2F6B6579776F72643E3C6B6579776F72643E4B65726E696374657275732F2A65706964656D696F6C6F67793C2F6B6579776F72643E3C6B6579776F72643E4D616C653C2F6B6579776F72643E3C6B6579776F72643E526567697374726965733C2F6B6579776F72643E3C6B6579776F72643E5269736B204173736573736D656E743C2F6B6579776F72643E3C2F6B6579776F7264733E3C64617465733E3C796561723E323031323C2F796561723E3C7075622D64617465733E3C646174653E4170723C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C6973626E3E313635312D323232372028456C656374726F6E696329262378443B303830332D3532353320284C696E6B696E67293C2F6973626E3E3C616363657373696F6E2D6E756D3E32323137363133333C2F616363657373696F6E2D6E756D3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E687474703A2F2F7777772E6E6362692E6E6C6D2E6E69682E676F762F7075626D65642F32323137363133333C2F75726C3E3C75726C3E687474703A2F2F6F6E6C696E656C6962726172792E77696C65792E636F6D2F73746F72652F31302E313131312F6A2E313635312D323232372E323031312E30323536352E782F61737365742F6A2E313635312D323232372E323031312E30323536352E782E7064663F763D3126616D703B743D693169673939317A26616D703B733D656635626334396138653232343766336465363437383532616561353331626139623330663932623C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C656C656374726F6E69632D7265736F757263652D6E756D3E31302E313131312F6A2E313635312D323232372E323031312E30323536352E783C2F656C656374726F6E69632D7265736F757263652D6E756D3E3C2F7265636F72643E3C2F436974653E3C436974653E3C417574686F723E56616E64626F72673C2F417574686F723E3C596561723E323031343C2F596561723E3C5265634E756D3E323532343C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E323532343C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2230223E323532343C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E56616E64626F72672C205065726E696C6C65204B3C2F617574686F723E3C617574686F723E48616E73656E2C20426F3C2F617574686F723E3C617574686F723E4772656973656E2C20473C2F617574686F723E3C617574686F723E4D617468696173656E2C20523C2F617574686F723E3C617574686F723E4B61737065722C20463C2F617574686F723E3C617574686F723E4562626573656E2C2046696E6E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C7469746C65733E3C7469746C653E466F6C6C6F772D7570206F662065787472656D65206E656F6E6174616C20687970657262696C69727562696E656D696120696E20352D20746F2031302D2079656172206F6C64206368696C6472656E3A20612044616E69736820706F70756C6174696F6E2D62617365642073747564793C2F7469746C653E3C7365636F6E646172792D7469746C653E446576656C6F706D656E74616C204D65646963696E6520616E64204368696C64204E6575726F6C6F67793C2F7365636F6E646172792D7469746C653E3C2F7469746C65733E3C64617465733E3C796561723E323031343C2F796561723E3C2F64617465733E3C75726C733E3C2F75726C733E3C2F7265636F72643E3C2F436974653E3C2F456E644E6F74653E</w:data>
</xml><![endif]><span style='mso-element:field-end'></span><span
style='mso-element:field-separator'></span></sup><![endif]--><span
style='mso-no-proof:yes'>[3-7]</span><sup><!--[if gte mso 9]><xml>
 <w:data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w:data>
</xml><![endif]--></sup><!--[if supportFields]><sup><span style='mso-element:
field-end'></span></sup><![endif]--></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level4 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lack of subtle adverse effects of bilirubin,
even when &#8805; 25 mg/dL <!--[if supportFields]><span style='mso-element:
field-begin'></span><span style='mso-spacerun:yes'></span>ADDIN EN.CITE <span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'></span>ADDIN EN.CITE.DATA <![if gte mso 9]><xml>
 <w:data>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</w:data>
</xml><![endif]><span style='mso-element:field-end'></span><span
style='mso-element:field-separator'></span><![endif]--><span style='mso-no-proof:
yes'>[7, 8]</span><!--[if gte mso 9]><xml>
 <w:data>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</w:data>
</xml><![endif]--><!--[if supportFields]><span style='mso-element:field-end'></span><![endif]--></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level4 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Internal inconsistency of guideline and high NNT<!--[if supportFields]><span
style='mso-element:field-begin'></span> ADDIN EN.CITE
&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Newman&lt;/Author&gt;&lt;Year&gt;2009&lt;/Year&gt;&lt;RecNum&gt;40&lt;/RecNum&gt;&lt;DisplayText&gt;[9]&lt;/DisplayText&gt;&lt;record&gt;&lt;rec-number&gt;40&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;key
app=&quot;EN&quot; db-id=&quot;zvsswrav8t2apbep2dbpv25ufvpprfe9rpex&quot;
timestamp=&quot;0&quot;&gt;40&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-type
name=&quot;Journal
Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Newman,
T. B.&lt;/author&gt;&lt;author&gt;Kuzniewicz, M.
W.&lt;/author&gt;&lt;author&gt;Liljestrand, P.&lt;/author&gt;&lt;author&gt;Wi,
S.&lt;/author&gt;&lt;author&gt;McCulloch,
C.&lt;/author&gt;&lt;author&gt;Escobar, G. J.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Department
of Epidemiology and Biostatistics, UCSF Box 0560, San Francisco, CA 94143, USA.
newman@epi.ucsf.edu&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Numbers
needed to treat with phototherapy according to American Academy of Pediatrics
guidelines&lt;/title&gt;&lt;secondary-title&gt;Pediatrics&lt;/secondary-title&gt;&lt;/titles&gt;&lt;periodical&gt;&lt;full-title&gt;Pediatrics&lt;/full-title&gt;&lt;/periodical&gt;&lt;pages&gt;1352-9&lt;/pages&gt;&lt;volume&gt;123&lt;/volume&gt;&lt;number&gt;5&lt;/number&gt;&lt;edition&gt;2009/05/01&lt;/edition&gt;&lt;keywords&gt;&lt;keyword&gt;Bilirubin/blood&lt;/keyword&gt;&lt;keyword&gt;Exchange
Transfusion, Whole Blood&lt;/keyword&gt;&lt;keyword&gt;Female&lt;/keyword&gt;&lt;keyword&gt;Guidelines
as
Topic/*standards&lt;/keyword&gt;&lt;keyword&gt;Humans&lt;/keyword&gt;&lt;keyword&gt;Infant,
Newborn&lt;/keyword&gt;&lt;keyword&gt;Jaundice,
Neonatal/*therapy&lt;/keyword&gt;&lt;keyword&gt;Logistic Models&lt;/keyword&gt;&lt;keyword&gt;Male&lt;/keyword&gt;&lt;keyword&gt;Phototherapy/*standards/statistics
&amp;amp; numerical data&lt;/keyword&gt;&lt;keyword&gt;Risk
Assessment&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2009&lt;/year&gt;&lt;pub-dates&gt;&lt;date&gt;May&lt;/date&gt;&lt;/pub-dates&gt;&lt;/dates&gt;&lt;isbn&gt;1098-4275
(Electronic)&lt;/isbn&gt;&lt;accession-num&gt;19403502&lt;/accession-num&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=19403502&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;electronic-resource-num&gt;123/5/1352
[pii]&amp;#xD;10.1542/peds.2008-1635&lt;/electronic-resource-num&gt;&lt;language&gt;eng&lt;/language&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<span
style='mso-element:field-separator'></span><![endif]--><span style='mso-no-proof:
yes'>[9]</span><!--[if supportFields]><span style='mso-element:field-end'></span><![endif]--></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level4 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Potential associations between phototherapy and
childhood cancer <!--[if supportFields]><span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'></span>ADDIN EN.CITE <span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'></span>ADDIN EN.CITE.DATA <![if gte mso 9]><xml>
 <w:data>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</w:data>
</xml><![endif]><span style='mso-element:field-end'></span><span
style='mso-element:field-separator'></span><![endif]--><span style='mso-no-proof:
yes'>[10-12]</span><!--[if gte mso 9]><xml>
 <w:data>3C456E644E6F74653E3C436974653E3C417574686F723E436E617474696E676975733C2F417574686F723E3C596561723E313939353C2F596561723E3C5265634E756D3E3730393C2F5265634E756D3E3C446973706C6179546578743E5B31302D31325D3C2F446973706C6179546578743E3C7265636F72643E3C7265632D6E756D6265723E3730393C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2230223E3730393C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E436E617474696E676975732C20532E3C2F617574686F723E3C617574686F723E5A61636B2C204D2E3C2F617574686F723E3C617574686F723E456B626F6D2C20412E3C2F617574686F723E3C617574686F723E47756E6E6172736B6F672C204A2E3C2F617574686F723E3C617574686F723E4C696E65742C204D2E3C2F617574686F723E3C617574686F723E4164616D692C20482E204F2E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C617574682D616464726573733E4465706172746D656E74206F66204F62737465747269637320616E642047796E6165636F6C6F67792C20556E697665727369747920486F73706974616C2C2055707073616C6120556E69766572736974792C2053776564656E2E3C2F617574682D616464726573733E3C7469746C65733E3C7469746C653E5072656E6174616C20616E64206E656F6E6174616C207269736B20666163746F727320666F72206368696C64686F6F64206D79656C6F6964206C65756B656D69613C2F7469746C653E3C7365636F6E646172792D7469746C653E43616E6365722045706964656D696F6C2042696F6D61726B65727320507265763C2F7365636F6E646172792D7469746C653E3C2F7469746C65733E3C70616765733E3434312D353C2F70616765733E3C766F6C756D653E343C2F766F6C756D653E3C6E756D6265723E353C2F6E756D6265723E3C65646974696F6E3E313939352F30372F30313C2F65646974696F6E3E3C6B6579776F7264733E3C6B6579776F72643E41646F6C657363656E743C2F6B6579776F72643E3C6B6579776F72643E4164756C743C2F6B6579776F72643E3C6B6579776F72643E436173652D436F6E74726F6C20537475646965733C2F6B6579776F72643E3C6B6579776F72643E4368696C643C2F6B6579776F72643E3C6B6579776F72643E4368696C642C205072657363686F6F6C3C2F6B6579776F72643E3C6B6579776F72643E436F6E666964656E636520496E74657276616C733C2F6B6579776F72643E3C6B6579776F72643E446F776E2053796E64726F6D652F636F6D706C69636174696F6E732F65706964656D696F6C6F67793C2F6B6579776F72643E3C6B6579776F72643E46656D616C653C2F6B6579776F72643E3C6B6579776F72643E466F6C6C6F772D557020537475646965733C2F6B6579776F72643E3C6B6579776F72643E48756D616E733C2F6B6579776F72643E3C6B6579776F72643E496E66616E743C2F6B6579776F72643E3C6B6579776F72643E496E66616E742C204E6577626F726E3C2F6B6579776F72643E3C6B6579776F72643E4A61756E646963652C204E656F6E6174616C2F636F6D706C69636174696F6E732F65706964656D696F6C6F67793C2F6B6579776F72643E3C6B6579776F72643E4C65756B656D69612C204D79656C6F69642F65706964656D696F6C6F67792F2A6574696F6C6F67793C2F6B6579776F72643E3C6B6579776F72643E4D616C653C2F6B6579776F72643E3C6B6579776F72643E4D617465726E616C204167653C2F6B6579776F72643E3C6B6579776F72643E4F64647320526174696F3C2F6B6579776F72643E3C6B6579776F72643E526567697374726965733C2F6B6579776F72643E3C6B6579776F72643E52656772657373696F6E20416E616C797369733C2F6B6579776F72643E3C6B6579776F72643E526574726F737065637469766520537475646965733C2F6B6579776F72643E3C6B6579776F72643E5269736B20466163746F72733C2F6B6579776F72643E3C6B6579776F72643E53776564656E2F65706964656D696F6C6F67793C2F6B6579776F72643E3C2F6B6579776F7264733E3C64617465733E3C796561723E313939353C2F796561723E3C7075622D64617465733E3C646174653E4A756C2D4175673C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C6973626E3E313035352D3939363520285072696E74293C2F6973626E3E3C616363657373696F6E2D6E756D3E373534393739373C2F616363657373696F6E2D6E756D3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E687474703A2F2F7777772E6E6362692E6E6C6D2E6E69682E676F762F656E7472657A2F71756572792E666367693F636D643D526574726965766526616D703B64623D5075624D656426616D703B646F70743D4369746174696F6E26616D703B6C6973745F756964733D373534393739373C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C6C616E67756167653E656E673C2F6C616E67756167653E3C2F7265636F72643E3C2F436974653E3C436974653E3C417574686F723E4E65776D616E3C2F417574686F723E3C596561723E323031363C2F596561723E3C5265634E756D3E333932373C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E333932373C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2230223E333932373C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E4E65776D616E2C20542E20422E3C2F617574686F723E3C617574686F723E5769636B72656D6173696E6768652C20412E20432E3C2F617574686F723E3C617574686F723E57616C73682C20452E204D2E3C2F617574686F723E3C617574686F723E4772696D65732C20422E20412E3C2F617574686F723E3C617574686F723E4D6343756C6C6F63682C20432E20452E3C2F617574686F723E3C617574686F723E4B757A6E69657769637A2C204D2E20572E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C617574682D616464726573733E4465706172746D656E7473206F662045706964656D696F6C6F677920616E642042696F737461746973746963732C20616E6420506564696174726963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F2C2043616C69666F726E69613B204469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E642C2043616C69666F726E69613B20616E64206E65776D616E406570692E756373662E6564752E262378443B4465706172746D656E7473206F662045706964656D696F6C6F677920616E642042696F737461746973746963732C20616E64204465706172746D656E74206F6620506564696174726963732C204B6169736572205065726D616E656E74652053616E746120436C6172612C2053616E746120436C6172612C2043616C69666F726E69612E262378443B4469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E642C2043616C69666F726E69613B20616E642E262378443B4465706172746D656E7473206F662045706964656D696F6C6F677920616E642042696F737461746973746963732C20616E642E262378443B506564696174726963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F2C2043616C69666F726E69613B204469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E642C2043616C69666F726E69613B20616E642E3C2F617574682D616464726573733E3C7469746C65733E3C7469746C653E526574726F737065637469766520436F686F7274205374756479206F662050686F746F7468657261707920616E64204368696C64686F6F642043616E63657220696E204E6F72746865726E2043616C69666F726E69613C2F7469746C653E3C7365636F6E646172792D7469746C653E506564696174726963733C2F7365636F6E646172792D7469746C653E3C2F7469746C65733E3C706572696F646963616C3E3C66756C6C2D7469746C653E506564696174726963733C2F66756C6C2D7469746C653E3C2F706572696F646963616C3E3C766F6C756D653E3133373C2F766F6C756D653E3C6E756D6265723E363C2F6E756D6265723E3C64617465733E3C796561723E323031363C2F796561723E3C7075622D64617465733E3C646174653E4A756E3C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C6973626E3E313039382D343237352028456C656374726F6E696329262378443B303033312D3430303520284C696E6B696E67293C2F6973626E3E3C616363657373696F6E2D6E756D3E32373231373437373C2F616363657373696F6E2D6E756D3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E687474703A2F2F7777772E6E6362692E6E6C6D2E6E69682E676F762F7075626D65642F32373231373437373C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C656C656374726F6E69632D7265736F757263652D6E756D3E31302E313534322F706564732E323031352D313335343C2F656C656374726F6E69632D7265736F757263652D6E756D3E3C2F7265636F72643E3C2F436974653E3C436974653E3C417574686F723E4E65776D616E3C2F417574686F723E3C596561723E323031363C2F596561723E3C5265634E756D3E333932373C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E333932373C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2230223E333932373C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E4E65776D616E2C20542E20422E3C2F617574686F723E3C617574686F723E5769636B72656D6173696E6768652C20412E20432E3C2F617574686F723E3C617574686F723E57616C73682C20452E204D2E3C2F617574686F723E3C617574686F723E4772696D65732C20422E20412E3C2F617574686F723E3C617574686F723E4D6343756C6C6F63682C20432E20452E3C2F617574686F723E3C617574686F723E4B757A6E69657769637A2C204D2E20572E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C617574682D616464726573733E4465706172746D656E7473206F662045706964656D696F6C6F677920616E642042696F737461746973746963732C20616E6420506564696174726963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F2C2043616C69666F726E69613B204469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E642C2043616C69666F726E69613B20616E64206E65776D616E406570692E756373662E6564752E262378443B4465706172746D656E7473206F662045706964656D696F6C6F677920616E642042696F737461746973746963732C20616E64204465706172746D656E74206F6620506564696174726963732C204B6169736572205065726D616E656E74652053616E746120436C6172612C2053616E746120436C6172612C2043616C69666F726E69612E262378443B4469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E642C2043616C69666F726E69613B20616E642E262378443B4465706172746D656E7473206F662045706964656D696F6C6F677920616E642042696F737461746973746963732C20616E642E262378443B506564696174726963732C20556E6976657273697479206F662043616C69666F726E69612C2053616E204672616E636973636F2C2043616C69666F726E69613B204469766973696F6E206F662052657365617263682C204B6169736572205065726D616E656E7465204E6F72746865726E2043616C69666F726E69612C204F616B6C616E642C2043616C69666F726E69613B20616E642E3C2F617574682D616464726573733E3C7469746C65733E3C7469746C653E526574726F737065637469766520436F686F7274205374756479206F662050686F746F7468657261707920616E64204368696C64686F6F642043616E63657220696E204E6F72746865726E2043616C69666F726E69613C2F7469746C653E3C7365636F6E646172792D7469746C653E506564696174726963733C2F7365636F6E646172792D7469746C653E3C2F7469746C65733E3C706572696F646963616C3E3C66756C6C2D7469746C653E506564696174726963733C2F66756C6C2D7469746C653E3C2F706572696F646963616C3E3C766F6C756D653E3133373C2F766F6C756D653E3C6E756D6265723E363C2F6E756D6265723E3C64617465733E3C796561723E323031363C2F796561723E3C7075622D64617465733E3C646174653E4A756E3C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C6973626E3E313039382D343237352028456C656374726F6E696329262378443B303033312D3430303520284C696E6B696E67293C2F6973626E3E3C616363657373696F6E2D6E756D3E32373231373437373C2F616363657373696F6E2D6E756D3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E687474703A2F2F7777772E6E6362692E6E6C6D2E6E69682E676F762F7075626D65642F32373231373437373C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C656C656374726F6E69632D7265736F757263652D6E756D3E31302E313534322F706564732E323031352D313335343C2F656C656374726F6E69632D7265736F757263652D6E756D3E3C2F7265636F72643E3C2F436974653E3C436974653E3C417574686F723E4672617A6965723C2F417574686F723E3C596561723E323031363C2F596561723E3C5265634E756D3E343036323C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E343036323C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2231353038373833333035223E343036323C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E4672617A6965722C20412E204C2E3C2F617574686F723E3C617574686F723E4B7261696C6F2C204D2E3C2F617574686F723E3C617574686F723E506F796E7465722C204A2E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C617574682D616464726573733E4465706172746D656E74206F6620506564696174726963204F6E636F6C6F67792C2044616E612D4661726265722043616E63657220496E737469747574652C2048617276617264204D65646963616C205363686F6F6C2C20426F73746F6E2C204D6173736163687573657474733B206C696E647361795F6672617A69657240646663692E686172766172642E6564752E262378443B4465706172746D656E74206F662050726576656E74697665204D65646963696E652C204B65636B205363686F6F6C206F66204D65646963696E652C20556E6976657273697479206F6620536F75746865726E2043616C69666F726E69612C204C6F7320416E67656C65732C2043616C69666F726E69613B20616E642E262378443B4469766973696F6E206F662045706964656D696F6C6F677920616E6420436C696E6963616C2052657365617263682C204465706172746D656E74206F6620506564696174726963732C20556E6976657273697479206F66204D696E6E65736F74612C204D696E6E6561706F6C69732C204D696E6E65736F74612E3C2F617574682D616464726573733E3C7469746C65733E3C7469746C653E43616E2042696720446174612053686564204C69676874206F6E20746865204F726967696E73206F66205065646961747269632043616E6365723F3C2F7469746C653E3C7365636F6E646172792D7469746C653E506564696174726963733C2F7365636F6E646172792D7469746C653E3C2F7469746C65733E3C706572696F646963616C3E3C66756C6C2D7469746C653E506564696174726963733C2F66756C6C2D7469746C653E3C2F706572696F646963616C3E3C766F6C756D653E3133373C2F766F6C756D653E3C6E756D6265723E363C2F6E756D6265723E3C64617465733E3C796561723E323031363C2F796561723E3C7075622D64617465733E3C646174653E4A756E3C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C6973626E3E313039382D343237352028456C656374726F6E696329262378443B303033312D3430303520284C696E6B696E67293C2F6973626E3E3C616363657373696F6E2D6E756D3E32373231373437393C2F616363657373696F6E2D6E756D3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E68747470733A2F2F7777772E6E6362692E6E6C6D2E6E69682E676F762F7075626D65642F32373231373437393C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C656C656374726F6E69632D7265736F757263652D6E756D3E31302E313534322F706564732E323031362D303938333C2F656C656374726F6E69632D7265736F757263652D6E756D3E3C2F7265636F72643E3C2F436974653E3C2F456E644E6F74653E00</w:data>
</xml><![endif]--><!--[if supportFields]><span style='mso-element:field-end'></span><![endif]-->
and epilepsy <!--[if supportFields]><span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'></span>ADDIN EN.CITE <span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'></span>ADDIN EN.CITE.DATA <![if gte mso 9]><xml>
 <w:data>3C456E644E6F74653E3C436974653E3C417574686F723E4D61696D627572673C2F417574686F723E3C596561723E323031363C2F596561723E3C5265634E756D3E343036313C2F5265634E756D3E3C446973706C6179546578743E5B31332C2031345D3C2F446973706C6179546578743E3C7265636F72643E3C7265632D6E756D6265723E343036313C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2231353038373833303831223E343036313C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E4D61696D627572672C20522E20442E3C2F617574686F723E3C617574686F723E4F6C73656E2C204A2E3C2F617574686F723E3C617574686F723E53756E2C20592E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C617574682D616464726573733E4465706172746D656E74206F6620436C696E6963616C204D65646963696E652C2041617268757320556E69766572736974792C204161726875732C2044656E6D61726B3B204465706172746D656E74206F662047796E6165636F6C6F677920616E64204F6273746574726963732C2041617268757320556E697665727369747920486F73706974616C2C20536B656A62792C2044656E6D61726B3B2043656E747265206F6620526573656172636820696E205265686162696C69746174696F6E2028434F524952292C2041617268757320556E697665727369747920486F73706974616C2C204161726875732C2044656E6D61726B2E20456C656374726F6E696320616464726573733A20726D616940636C696E2E61752E646B2E262378443B4465706172746D656E74206F6620436C696E6963616C2045706964656D696F6C6F67792C2041617268757320556E697665727369747920486F73706974616C2C204161726875732C2044656E6D61726B3B2053656374696F6E206F662045706964656D696F6C6F67792C205363686F6F6C206F66205075626C6963204865616C74682C20556E6976657273697479206F662043616C69666F726E6961206174204C6F7320416E67656C65732C2043412C205553412E20456C656374726F6E696320616464726573733A206A6F40736F63692E61752E646B2E262378443B4465706172746D656E74206F6620436C696E6963616C2045706964656D696F6C6F67792C2041617268757320556E697665727369747920486F73706974616C2C204161726875732C2044656E6D61726B2E20456C656374726F6E696320616464726573733A2073756E40736F63692E61752E646B2E3C2F617574682D616464726573733E3C7469746C65733E3C7469746C653E4E656F6E6174616C20687970657262696C69727562696E656D696120616E6420746865207269736B206F662066656272696C65207365697A7572657320616E64206368696C64686F6F64206570696C657073793C2F7469746C653E3C7365636F6E646172792D7469746C653E4570696C65707379205265733C2F7365636F6E646172792D7469746C653E3C2F7469746C65733E3C706572696F646963616C3E3C66756C6C2D7469746C653E4570696C65707379205265733C2F66756C6C2D7469746C653E3C2F706572696F646963616C3E3C70616765733E36372D37323C2F70616765733E3C766F6C756D653E3132343C2F766F6C756D653E3C6B6579776F7264733E3C6B6579776F72643E4570696C657073793C2F6B6579776F72643E3C6B6579776F72643E46656272696C65207365697A7572653C2F6B6579776F72643E3C6B6579776F72643E487970657262696C69727562696E656D69613C2F6B6579776F72643E3C6B6579776F72643E4A61756E646963653C2F6B6579776F72643E3C6B6579776F72643E4E656F6E6174616C3C2F6B6579776F72643E3C2F6B6579776F7264733E3C64617465733E3C796561723E323031363C2F796561723E3C7075622D64617465733E3C646174653E4175673C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C6973626E3E313837322D363834342028456C656374726F6E696329262378443B303932302D3132313120284C696E6B696E67293C2F6973626E3E3C616363657373696F6E2D6E756D3E32373235393037313C2F616363657373696F6E2D6E756D3E3C75726C733E3C72656C617465642D75726C733E3C75726C3E68747470733A2F2F7777772E6E6362692E6E6C6D2E6E69682E676F762F7075626D65642F32373235393037313C2F75726C3E3C2F72656C617465642D75726C733E3C2F75726C733E3C656C656374726F6E69632D7265736F757263652D6E756D3E31302E313031362F6A2E65706C657073797265732E323031362E30352E3030343C2F656C656374726F6E69632D7265736F757263652D6E756D3E3C2F7265636F72643E3C2F436974653E3C43697465204578636C756465596561723D2231223E3C417574686F723E4E65776D616E3C2F417574686F723E3C596561723E2050656E64696E673C2F596561723E3C5265634E756D3E343036333C2F5265634E756D3E3C7265636F72643E3C7265632D6E756D6265723E343036333C2F7265632D6E756D6265723E3C666F726569676E2D6B6579733E3C6B6579206170703D22454E222064622D69643D227A7673737772617638743261706265703264627076323575667670707266653972706578222074696D657374616D703D2231353038373833343138223E343036333C2F6B65793E3C2F666F726569676E2D6B6579733E3C7265662D74797065206E616D653D224A6F75726E616C2041727469636C65223E31373C2F7265662D747970653E3C636F6E7472696275746F72733E3C617574686F72733E3C617574686F723E4E65776D616E2C20542E20422E3C2F617574686F723E3C617574686F723E57752C20593C2F617574686F723E3C617574686F723E4772696D65732C20422E20412E3C2F617574686F723E3C617574686F723E4D6343756C6C6F63682C20432E20452E3C2F617574686F723E3C617574686F723E4B757A6E69657769637A2C204D2E20572E3C2F617574686F723E3C2F617574686F72733E3C2F636F6E7472696275746F72733E3C7469746C65733E3C7469746C653E50686F746F7468657261707920616E64207269736B206F662073756273657175656E74207365697A757265733C2F7469746C653E3C7365636F6E646172792D7469746C653E576F726B20696E2070726F67726573733C2F7365636F6E646172792D7469746C653E3C2F7469746C65733E3C706572696F646963616C3E3C66756C6C2D7469746C653E576F726B20696E2070726F67726573733C2F66756C6C2D7469746C653E3C2F706572696F646963616C3E3C64617465733E3C796561723E2050656E64696E673C2F796561723E3C7075622D64617465733E3C646174653E4A756E3C2F646174653E3C2F7075622D64617465733E3C2F64617465733E3C75726C733E3C2F75726C733E3C2F7265636F72643E3C2F436974653E3C2F456E644E6F74653E00</w:data>
</xml><![endif]><span style='mso-element:field-end'></span><span
style='mso-element:field-separator'></span><![endif]--><span style='mso-no-proof:
yes'>[13, 14]</span><!--[if gte mso 9]><xml>
 <w:data>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</w:data>
</xml><![endif]--><!--[if supportFields]><span style='mso-element:field-end'></span><![endif]--></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level1 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>UCSF NC<sup>2</sup> Consensus Guidelines goals</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l9 level3 lfo4'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Update hyperbilirubinemia clinical practice
recommendations based on recent research</p>

<p class=MsoListParagraphCxSpLast style='margin-left:1.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l9 level4 lfo4'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Draw on Kaiser Permanente Northern California
(KPNC) experience with updated practice guidelines<span
style='mso-spacerun:yes'> </span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-spacerun:yes'></span>[NOTE: Parts II-IV apply to neonates </b><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Cambria",serif'>&#8805;</span>
35 weeks gestational age (GA)]</b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>PART II: Jaundice
&amp; bilirubin screening <o:p></o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l8 level1 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Blood Typing</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level2 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Newborn cord blood should be sent to blood bank
on all newborns, with testing in the following circumstances:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level3 lfo2'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Rh neg mother <span style='font-family:Wingdings;
mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:
Calibri;mso-hansi-theme-font:minor-latin;mso-char-type:symbol;mso-symbol-font-family:
Wingdings'><span style='mso-char-type:symbol;mso-symbol-font-family:Wingdings'></span></span>
Rh type + direct antiglobulin test (DAT)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level3 lfo2'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>O pos mother <span style='font-family:Wingdings;
mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:
Calibri;mso-hansi-theme-font:minor-latin;mso-char-type:symbol;mso-symbol-font-family:
Wingdings'><span style='mso-char-type:symbol;mso-symbol-font-family:Wingdings'></span></span>
DAT only</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level4 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'>NOTE:</i>
ABO group unnecessary, does not change management (e.g. neonate is low risk if
DAT negative, regardless of ABO group) </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level4 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'>OPTION:</i>
send cord blood to blood bank to hold on infants born to O pos mothers; order
DAT (and other studies) only <i style='mso-bidi-font-style:normal'>IF</i>
clinical jaundice is noted</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level3 lfo2'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Maternal antibody screen positive <span
style='font-family:Wingdings;mso-ascii-font-family:Calibri;mso-ascii-theme-font:
minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;
mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span style='mso-char-type:
symbol;mso-symbol-font-family:Wingdings'></span></span> DAT </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level4 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'>Consider: </i>cord
blood bilirubin level</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level3 lfo2'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Maternal blood type and antibody screen unknown <span
style='font-family:Wingdings;mso-ascii-font-family:Calibri;mso-ascii-theme-font:
minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;
mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span style='mso-char-type:
symbol;mso-symbol-font-family:Wingdings'></span></span> DAT</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level3 lfo2'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'>NOTE: </i>Blood
bank can hold cord blood / peripheral blood specimen for further testing if
requested</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level3 lfo2'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>If cord blood was not sent to the blood bank
initially, OK to wait for jaundice or other clinical indication for blood
type/group/DAT except in Rh-negative mothers</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level1 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Transcutaneous Bilirubin (TcB) Screening</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level2 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>24-48hrs of life in all neonates and/or prior to
discharge</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level2 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Anytime jaundice is detected</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level2 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Earlier + more frequent screening if DAT
positive</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level2 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Frequent re-assessment if TcB close to
phototherapy threshold or rapidly rising</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level1 lfo2'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Total Serum Bilirubin (TsB) Testing</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level2 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>TcB within 3 mg/dL of phototherapy threshold </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l8 level2 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Consider if TcB &gt;12-13 (TcB less accurate
above this range)</p>

<p class=MsoListParagraphCxSpLast style='margin-left:.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l8 level2 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Follow TsB if TcB &gt;13 or if TsB has been
&gt;15 until declining </p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>PART III: Treatment<o:p></o:p></b></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Medical Management<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>General recommendations<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Lactation support; oral hydration if
dehydrated<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>AGGRESSIVE MEDICAL THERAPY: for babies
within two mg/dL of NCNC <b style='mso-bidi-font-weight:normal'>exchange
transfusion</b> threshold, or rapidly rising (&gt;7 mg/dL in 24hrs or &gt;
0.3mg/dL per hour)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Aggressive IV + PO hydration<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Intensive phototherapy<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Monitor TsB every 2-4 hours depending
on previous rate of rise<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:1.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Consult with neonatologist re:
additional therapies (e.g. IVIG)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:1.0in'><span style='color:black;
mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Phototherapy Thresholds<sup>1</sup> </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Basic recommendations:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]>Identify
<b style='mso-bidi-font-weight:normal'>neurotoxicity risk factors</b>:<span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Isoimmune hemolytic disease, G6PD
deficiency,&nbsp;or other hemolytic disease<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Sepsis&nbsp;or suspected sepsis
(sufficient to be currently on antibiotics)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Acidosis (BE &#8804; &nbsp;&#8722;8
meq/L&nbsp;or pCO2 &gt;50 mmHg within the last 24 hr)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Albumin &lt;3.0 mg/dL<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:1.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Any clinical instability<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:9.0pt;font-family:"Arial",sans-serif;
color:black'>&nbsp;</span><span style='font-family:SimSun;mso-fareast-font-family:
"MS Mincho";mso-fareast-theme-font:minor-fareast;mso-bidi-font-family:"Times New Roman";
color:black'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>TsB within 1-2 mg/dL below NCNC <b
style='mso-bidi-font-weight:normal'>phototherapy</b> threshold = CONSIDER
PHOTOTHERAPY</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Optimize feeding (breastfeeding support,
supplement, formula, etc)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Repeat TsB @ 4-24hrs (prior to discharge if
during birth admission)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Consider phototherapy (including home
phototherapy if available)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'>NOTE: NCNC
</i>threshold to initiate phototherapy is lower for younger gestational ages,
rapid rate of rise, or neurotoxicity risk factors (i.e. medium risk or
higher risk infants)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>TsB &#8805; <span style='font-family:"Cambria",serif'>NCNC
threshold</span> = PERFORM PHOTOTHERAPY</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Start phototherapy </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Optimize feeding (as above)</p>

<p class=MsoListParagraphCxSpLast style='margin-left:1.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>If there is suspicion for hemolysis or other
underlying causes of hyperbilirubinemia (G6PD, sepsis, etc), it is appropriate
to start phototherapy at the threshold for newborns with neurotoxicity risk
factors and proceed with an appropriate work up for those causes. </p>

<p class=MsoNormal><span style='mso-ascii-font-family:Calibri;mso-fareast-font-family:
"Times New Roman";mso-hansi-font-family:Calibri;mso-bidi-font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='mso-ascii-font-family:Calibri;mso-fareast-font-family:
"Times New Roman";mso-hansi-font-family:Calibri;mso-bidi-font-family:"Times New Roman"'>For
example, for a 38 0/7-week formula-fed African American male at 96 hours of
age, if the TSB were 19.0 mg/dL, it would be appropriate to start phototherapy
(and check the G6PD activity) even though the threshold used if neurotoxicity
risk factors are absent would be 20.4. This is because the threshold would be
18.2 if neurotoxicity risk factor were present and the clinical picture
suggests G6PD deficiency, a neurotoxicity risk factor for which confirmation is
often not immediately available.</span><br>
<br>
<span style='font-size:10.0pt;font-family:Symbol;mso-ascii-font-family:Times;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times New Roman"'></span><span
style='font-size:10.0pt;font-family:"Times",serif;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman"'><span style='mso-spacerun:yes'>
</span></span><span style='mso-ascii-font-family:Calibri;mso-fareast-font-family:
"Times New Roman";mso-hansi-font-family:Calibri;mso-bidi-font-family:"Times New Roman"'><br
style='mso-special-character:line-break'>
<![if !supportLineBreakNewLine]><br style='mso-special-character:line-break'>
<![endif]></span><span style='font-size:10.0pt;font-family:"Times",serif;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times New Roman"'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:Symbol;mso-ascii-font-family:
Times;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times New Roman"'></span><span
style='font-size:10.0pt;font-family:"Times",serif;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman"'><span style='mso-spacerun:yes'>
</span></span><span style='mso-ascii-font-family:Calibri;mso-fareast-font-family:
"Times New Roman";mso-hansi-font-family:Calibri;mso-bidi-font-family:"Times New Roman"'>&nbsp;</span><span
style='font-size:10.0pt;font-family:"Times",serif;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman"'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'>CONSIDER: </i>Higher
threshold for readmission for phototherapy if infant at home (<span
style='font-family:"Cambria",serif'>&#8805;</span> 2-3 days of life) versus the
threshold for phototherapy during the birth admission </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpLast style='margin-left:.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Customized thresholds: Individualized thresholds
based on exact gestational age, neurotoxicity risk factors, and hours of life:</p>

<p class=MsoNormal><span style='mso-spacerun:yes'></span><span
style='mso-no-proof:yes'><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_4" o:spid="_x0000_i1029" type="#_x0000_t75"
 style='width:396pt;height:4in;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image001.emz"
  o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=528 height=384
src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image002.png" v:shapes="Picture_x0020_4"><![endif]></span></p>

<p class=MsoNormal>Figure 1: New Phototherapy Thresholds for babies with no
neurotoxicity risk factors (NT RF)</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><span style='mso-no-proof:yes'><!--[if gte vml 1]><v:shape
 id="Picture_x0020_3" o:spid="_x0000_i1028" type="#_x0000_t75" style='width:396pt;
 height:4in;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image003.emz"
  o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=528 height=384
src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image004.png" v:shapes="Picture_x0020_3"><![endif]></span></p>

<p class=MsoNormal>Figure 2: New Phototherapy Thresholds for babies with neurotoxicity
risk factors (NT RF)</p>

<p class=MsoListParagraphCxSpFirst style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>See website for calculator: <span
style='mso-spacerun:yes'></span><a href="http://www.phototherapyguidelines.com">www.phototherapyguidelines.com</a><br>
<br>
Guideline soon to be housed at:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto'><a href="https://www.ucsfbenioffchildrens.org/neonatal_consortium/">https://www.ucsfbenioffchildrens.org/neonatal_consortium/</a><span
class=MsoHyperlink><span style='color:windowtext;text-decoration:none;
text-underline:none'><o:p></o:p></span></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:1.75in;mso-add-space:auto'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><span style='color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Exchange Transfusion Thresholds<sup>2</sup><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Basic Recommendations:<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Consultation with neonatologist when
infants have bilirubin within 2 mg/dL of NCNC exchange transfusion threshold or
rapidly rising (&gt;7 mg/dL in 24 hours or &gt;0.3mg/dL/hr), particularly in
first 48 hours of life<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>INITIAL bilirubin (e.g. no prior
bilirubin measurement or intervention)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-family:"Cambria",serif;color:black;mso-themecolor:text1'>&gt;</span><span
style='color:black;mso-themecolor:text1'> 2 mg/dL above NCNC Exchange
Transfusion threshold = PREPARE FOR IMMEDIATE EXCHANGE TRANSFUSION</span><span
style='font-family:Symbol;mso-ascii-font-family:Calibri;mso-ascii-theme-font:
minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;
color:black;mso-themecolor:text1;mso-char-type:symbol;mso-symbol-font-family:
Symbol'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'></span></span><span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Perform aggressive medical therapy as
above while preparing for exchange transfusion OR initiating transfer to
institution capable of performing exchange transfusion<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-family:"Cambria",serif;color:black;mso-themecolor:text1'>0-2 mg/dL
above NCNC threshold = CONSIDER EXCHANGE TRANSFUSION</span><span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Aggressive medical therapy as above<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Strongly consider transfer to
institution capable of performing exchange transfusion<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>0-2 mg/dL below NCNC Threshold <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'><span
style='mso-spacerun:yes'></span>Aggressive medical therapy as above<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>See flow chart for full
recommendations<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:2.25in;mso-add-space:auto'><span
style='color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:black;mso-themecolor:text1;mso-no-proof:
yes'><!--[if gte vml 1]><v:shape id="Picture_x0020_5" o:spid="_x0000_i1027"
 type="#_x0000_t75" style='width:443.25pt;height:571.9pt;visibility:visible;
 mso-wrap-style:square'>
 <v:imagedata src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image005.jpg"
  o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=591 height=763
src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image006.jpg" v:shapes="Picture_x0020_5"><![endif]></span><span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Figure 3:
Exchange Transfusion Recommendations Near NCNC Exchange Transfusion Threshold<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='mso-spacerun:yes'></span>Customized
thresholds: Individualized thresholds based on exact gestational age,
neurotoxicity risk factors, and hours of life:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:0in;mso-add-space:auto'><span
style='mso-no-proof:yes'><!--[if gte vml 1]><v:shape id="Picture_x0020_9"
 o:spid="_x0000_i1026" type="#_x0000_t75" style='width:387pt;height:259.5pt;
 visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image007.png"
  o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=516 height=346
src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image008.png" v:shapes="Picture_x0020_9"><![endif]></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:0in;mso-add-space:auto'>Figure
4: New Exchange Transfusion Thresholds for Babies WITHOUT Neurotoxicity Risk
Factors </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:0in;mso-add-space:auto'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:0in;mso-add-space:auto'><span
style='mso-no-proof:yes'><!--[if gte vml 1]><v:shape id="Picture_x0020_10"
 o:spid="_x0000_i1025" type="#_x0000_t75" style='width:387pt;height:282pt;
 visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image009.png"
  o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=516 height=376
src="NeoHyperbilirubinemiaGuidelineFINAL_2018-0209_files/image009.png" v:shapes="Picture_x0020_10"><![endif]></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:0in;mso-add-space:auto'>Figure
5: New Exchange Transfusion Thresholds for Babies WITH Neurotoxicity Risk
Factors (NT RF)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l4 level1 lfo6'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='color:black;mso-themecolor:text1'>IVIG:</span>
for isoimmune hemolytic anemia ONLY</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l4 level2 lfo6'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='mso-bidi-font-family:Helvetica;
color:#191919'>IVIG 1g/kg&nbsp;IV over 2 hours if the Total Serum Bilirubin is
rising despite intensive phototherapy. May repeat x1 after 12 hours of first
dose. (With an acceptable range of 0.5g/kg to 1g/kg  round to vial size)</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l4 level2 lfo6'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='mso-bidi-font-family:Helvetica;
color:#191919'>For hemolytic jaundice that is NOT isoimmune, consult Neonatologist
or Hematologist</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto'><span style='color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Bilirubin monitoring<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Prior to initiation of phototherapy:<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><i
style='mso-bidi-font-style:normal'><span style='color:black;mso-themecolor:
text1'>NOTE: </span></i><span style='color:black;mso-themecolor:text1'>For
infants readmitted for phototherapy, if last TsB was &gt;4-6 hours prior,
repeat TsB<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>During phototherapy:<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>For all infants, check TsB within 12 hours
of initiation of phototherapy<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>TsB <span
style='mso-spacerun:yes'></span>~ q12 hours:<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>No hemolytic disease or rapid rate of
rise<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>TsB within 6-8 hours:<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Evidence or suspicion of hemolytic
disease <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Rapid rate of rise (&gt;7 mg/dL/24
hours or &gt;0.3mg/dL/hr)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>Other neurotoxicity risk factors (i.e.
sepis or acidosis)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level4 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black;mso-themecolor:text1'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'>TsB q2-4 hours:<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:2.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level5 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New";
color:black;mso-themecolor:text1'><span style='mso-list:Ignore'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='color:black;mso-themecolor:text1'><span
style='mso-spacerun:yes'></span>Bilirubin within 1-2 mg/dL of NCNC threshold
for exchange transfusion <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><i style='mso-bidi-font-style:normal'><span
style='color:black;mso-themecolor:text1'>NOTE</span></i><span style='color:
black;mso-themecolor:text1'>: all bilirubin monitoring during phototherapy
should be done via serum bilirubin levels; transcutaneous bilirubin is not accurate
</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Discontinuation of Phototherapy</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Discontinue phototherapy when TsB is at least
2-3 mg/dL below the phototherapy initiation threshold</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Indications for longer course of phototherapy:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Ongoing feeding difficulty</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Prematurity (&lt; 37 weeks GA)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Slow rate of decrease while on phototherapy</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Hemolytic jaundice</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hydration and nutrition considerations:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Support breastfeeding</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Consider enteral supplementation with expressed
breast milk, formula, etc</p>

<p class=MsoListParagraphCxSpLast style='margin-left:.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Consider IV fluids only if close to exchange
transfusion or if other indications for IV fluids</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rebound bilirubin measurement:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Indications for ordering rebound TsB:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Hemolytic jaundice </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Prematurity (&lt;37 weeks GA)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>If phototherapy is discontinued sooner than 2-3
mg/dL below the phototherapy initiation threshold </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level3 lfo1'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>If phototherapy was started prior to 48 hours</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Timing: 6-24 hours</p>

<p class=MsoListParagraphCxSpLast style='margin-left:.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>TcB may be inaccurate following
phototherapy.<span style='mso-spacerun:yes'> </span>Use TsB in this setting.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>PART IV: Discharge
&amp; Follow-up<o:p></o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Discharge Criteria</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Off phototherapy and otherwise well</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Feeding adequately</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.75in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Follow-up arranged for 24-48hrs</p>

<p class=MsoListParagraphCxSpLast style='margin-left:.75in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level2 lfo1'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Expectation that additional phototherapy will
not be necessary</p>

<span style='font-size:12.0pt;font-family:"Calibri",sans-serif;mso-ascii-theme-font:
minor-latin;mso-fareast-font-family:"MS Mincho";mso-fareast-theme-font:minor-fareast;
mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal>Footnotes<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></p>

<p class=MsoListParagraph style='text-indent:-.25in;mso-list:l7 level1 lfo7'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'>Methodology
for determining new phototherapy thresholds/calculator: <o:p></o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>The starting point
for the new thresholds were the 2004 AAP guidelines.<span
style='mso-spacerun:yes'> </span>On examination of new data, the evidence
since 2004 suggested raising thresholds, given the extremely low rates of
kernicterus and the possible risk of phototherapy causing adverse outcomes.<span
style='mso-spacerun:yes'> </span>Therefore, for babies with no NT risk factors
we added 2 mg/dL to the 2004 AAP low risk threshold for 40-week babies and 1 mg/dL
to the AAP MRT for 35-week babies, then adjusted for individualized gestational
age.<span style='mso-spacerun:yes'> </span>For babies with NT risk factors we
added 1 mg/dL for infants &#8805; 38 weeks and nothing for 35 week infants,
then adjusted for individualized gestational age.<o:p></o:p></b></p>

<p class=MsoListParagraph style='text-indent:-.25in;mso-list:l7 level1 lfo7'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'>Methodology
for determining new exchange transfusion thresholds/calculator: <o:p></o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>The starting point
for the new thresholds were the 2004 AAP guidelines.<span
style='mso-spacerun:yes'> </span>On examination of new data, the evidence
since 2004 suggested raising thresholds, given the extremely low rates of
kernicterus.<span style='mso-spacerun:yes'> </span>Therefore, for babies with
no NT risk factors we added 0 to the AAP low-risk threshold at birth and 5 mg/dL
to the 2004 AAP low risk threshold at 96 hours for 40 week babies and 0 at
birth and 3 mg/dL at 96 hours to the threshold for 35-week then adjusted for
individualized age (if &lt; 96 hours) and gestational age.<span
style='mso-spacerun:yes'> </span><o:p></o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>For babies with NT
risk factors we added 0 to the AAP medium risk threshold for 40 week babies at
birth and 3 mg/dL to the AAP medium risk threshold for 40-week babies at 96
hours; the changes from the AAP guidelines increase from 0 at birth to 3 mg/dL
at 96 hours.<span style='mso-spacerun:yes'> </span>We added nothing to the AAP
high-risk threshold for 35-week babies.<span style='mso-spacerun:yes'>
</span>We then adjusted for individualized age (if &lt; 96 hours) and gestational
age. <o:p></o:p></b></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal style='margin-left:.5in'><b style='mso-bidi-font-weight:
normal'><o:p>&nbsp;</o:p></b></p>

<span style='font-size:12.0pt;font-family:"Calibri",sans-serif;mso-ascii-theme-font:
minor-latin;mso-fareast-font-family:"MS Mincho";mso-fareast-theme-font:minor-fareast;
mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto'><o:p>&nbsp;</o:p></p>

<p class=MsoListParagraphCxSpLast style='margin-left:.25in;mso-add-space:auto'><o:p>&nbsp;</o:p></p>

<p class=EndNoteBibliographyTitle><!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'></span>ADDIN EN.REFLIST <span style='mso-element:
field-separator'></span><![endif]--><span style='mso-no-proof:yes'>REFERENCES<o:p></o:p></span></p>

<p class=EndNoteBibliographyTitle><span style='mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>1.<span style='mso-tab-count:1'> </span>Maisels,
M.J., et al., <i style='mso-bidi-font-style:normal'>Management of hyperbilirubinemia
in the newborn infant 35 or more weeks of gestation.</i> Pediatrics, 2004. <b
style='mso-bidi-font-weight:normal'>114</b>(1): p. 297-316.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>2.<span style='mso-tab-count:1'> </span>Brooks,
J.C., et al., <i style='mso-bidi-font-style:normal'>Evidence suggests there was
not a &quot;resurgence&quot; of kernicterus in the 1990s.</i> Pediatrics, 2011.
<b style='mso-bidi-font-weight:normal'>127</b>(4): p. 672-9.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>3.<span style='mso-tab-count:1'> </span>Gamaleldin,
R., et al., <i style='mso-bidi-font-style:normal'>Risk factors for
neurotoxicity in newborns with severe neonatal hyperbilirubinemia.</i>
Pediatrics, 2011. <b style='mso-bidi-font-weight:normal'>128</b>(4): p.
e925-31.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>4.<span style='mso-tab-count:1'> </span>Kuzniewicz,
M.W., et al., <i style='mso-bidi-font-style:normal'>Incidence, Etiology, and
Outcomes of Hazardous Hyperbilirubinemia in Newborns.</i> Pediatrics, 2014: p.
peds.2014-0987.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>5.<span style='mso-tab-count:1'> </span>Wu,
Y.W., et al., <i style='mso-bidi-font-style:normal'>Risk for cerebral palsy in
infants with total serum bilirubin levels at or above the exchange transfusion
threshold: a population-based study.</i> JAMA Pediatr, 2015. <b
style='mso-bidi-font-weight:normal'>169</b>(3): p. 239-46.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>6.<span style='mso-tab-count:1'> </span>Ebbesen,
F., J.V. Bjerre, and P.K. Vandborg, <i style='mso-bidi-font-style:normal'>Relation
between serum bilirubin levels &gt;/=450 mumol/L and bilirubin encephalopathy;
a Danish population-based study.</i> Acta Paediatr, 2012. <b style='mso-bidi-font-weight:
normal'>101</b>(4): p. 384-9.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>7.<span style='mso-tab-count:1'> </span>Vandborg,
P.K., et al., <i style='mso-bidi-font-style:normal'>Follow-up of extreme
neonatal hyperbilirubinemia in 5- to 10- year old children: a Danish
population-based study.</i> Developmental Medicine and Child Neurology, 2014.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>8.<span style='mso-tab-count:1'> </span>Newman,
T.B., et al., <i style='mso-bidi-font-style:normal'>Outcomes among newborns
with total serum bilirubin levels of 25 mg per deciliter or more.</i> N Engl J
Med, 2006. <b style='mso-bidi-font-weight:normal'>354</b>(18): p. 1889-900.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>9.<span style='mso-tab-count:1'> </span>Newman,
T.B., et al., <i style='mso-bidi-font-style:normal'>Numbers needed to treat
with phototherapy according to American Academy of Pediatrics guidelines.</i>
Pediatrics, 2009. <b style='mso-bidi-font-weight:normal'>123</b>(5): p. 1352-9.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>10.<span style='mso-tab-count:1'> </span>Cnattingius,
S., et al., <i style='mso-bidi-font-style:normal'>Prenatal and neonatal risk
factors for childhood myeloid leukemia.</i> Cancer Epidemiol Biomarkers Prev,
1995. <b style='mso-bidi-font-weight:normal'>4</b>(5): p. 441-5.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>11.<span style='mso-tab-count:1'> </span>Newman,
T.B., et al., <i style='mso-bidi-font-style:normal'>Retrospective Cohort Study
of Phototherapy and Childhood Cancer in Northern California.</i> Pediatrics,
2016. <b style='mso-bidi-font-weight:normal'>137</b>(6).<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>12.<span style='mso-tab-count:1'> </span>Frazier,
A.L., M. Krailo, and J. Poynter, <i style='mso-bidi-font-style:normal'>Can Big
Data Shed Light on the Origins of Pediatric Cancer?</i> Pediatrics, 2016. <b
style='mso-bidi-font-weight:normal'>137</b>(6).<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>13.<span style='mso-tab-count:1'> </span>Maimburg,
R.D., J. Olsen, and Y. Sun, <i style='mso-bidi-font-style:normal'>Neonatal
hyperbilirubinemia and the risk of febrile seizures and childhood epilepsy.</i>
Epilepsy Res, 2016. <b style='mso-bidi-font-weight:normal'>124</b>: p. 67-72.<o:p></o:p></span></p>

<p class=EndNoteBibliography style='margin-left:.5in;text-indent:-.5in'><span
style='mso-no-proof:yes'>14.<span style='mso-tab-count:1'> </span>Newman,
T.B., et al., <i style='mso-bidi-font-style:normal'>Phototherapy and risk of
subsequent seizures.</i> Work in progress, Pending.<o:p></o:p></span></p>

<p class=MsoListParagraph style='margin-left:.25in;mso-add-space:auto'><!--[if supportFields]><span
style='mso-element:field-end'></span><![endif]--><o:p>&nbsp;</o:p></p>

</div>

</body>

</html>
